Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Withdrawal of Infanrix HepB marketing authorization in Europe

Aug. 8, 2005

CytoGenix and Aldevron collaborate on DNA vaccine technology

Aug. 8, 2005

CholeraGarde reported safe and immunogenic in children and infants

Aug. 4, 2005

IL-24's role in immune regulation

Aug. 2, 2005

DOR and Dowpharma sign joint development agreement for BT-VACC

Aug. 1, 2005

Identification of a potent and selective histamine H4 receptor agonist

July 29, 2005

Adacel vaccine now available in U.S.

July 28, 2005

Merck achieves milestone using Transgene technology

July 26, 2005

Oral low-dose interferon alpha to be studied for Behcet's disease

July 25, 2005

New phase II trial for Imvamune in HIV patients

July 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...